Skip to main content

Jonathan E. Anderman

Equibles does not estimate personal net worth.

About Jonathan E. Anderman

Jonathan E. Anderman is recorded as General Counsel at Compass Therapeutics, Inc. (CMPX). The newest filing on record that lists Jonathan E. Anderman as General Counsel at Compass Therapeutics, Inc. (CMPX) is dated April 29, 2026. The proxy statement of Compass Therapeutics, Inc. reports total compensation of $1,427,800 for Jonathan E. Anderman in fiscal 2025, including a base salary of $450,000. Disclosed compensation is on record for 3 fiscal years. Compass Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Compass Therapeutics, Inc. includes Thomas J. Schuetz (CEO and Board Member), Thomas Schuetz (CEO and Board Member), Thomas Schuetz, MD, PhD (CEO and Chairman) and 7 others.

Affiliation history

Company network

Leadership on record at Compass Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Compass Therapeutics, Inc. (CMPX) $450,000 $1,427,800
2024 Compass Therapeutics, Inc. (CMPX) $326,820 $893,635
2023 Compass Therapeutics, Inc. (CMPX) $338,000 $707,948

Recent activity

No call appearances or filed executive changes recorded yet.